HOME >> MEDICINE >> NEWS
Drug shows promise in treating severe, often-lethal complication of stem cell transplants

BOSTON A study led by researchers at Dana-Farber Cancer Institute has shown that a drug extracted from porcine intestinal tissue reduced the risk of death in patients who experienced a severe and often-fatal complication of stem cell transplants.

The experimental drug defibrotide reversed severe veno-occlusive disease (VOD) of the liver in more than one third of the stem cell transplant recipients enrolled in the study. VOD is a type of potentially fatal liver damage that can result from the high doses of chemotherapy given prior to a transplant. The findings, which will be published in the Dec. 15 issue of Blood, have been posted as a "First Edition Paper" on the journal's web site (www.bloodjournal.org).

"Stem cell transplant patients suffering from severe veno-occlusive disease are at a very high risk of death, with a mortality rate in excess of 90 percent. The results from this study are compelling, especially given the remarkable safety of the drug in this extremely sick population," says Paul G. Richardson, MD, a hematologic oncologist at Dana-Farber who led the multi-center study. "This trial, which is the largest of its kind to date, confirms prior reports from smaller studies, and provides a strong platform for us to move forward with further trials of defibrotide, both in therapy for established VOD and its prevention."

Five to 60 percent of stem cell transplant patients develop VOD, which ranges in severity from mild and reversible to severe and almost always fatal. Stem cell recipients have an elevated risk for VOD due to the high-dose chemotherapy they undergo prior to transplantation and the type of transplant they have, with allogeneic (unrelated or related donor stem cells) transplant recipients being at greater risk than autologous recipients (using the patient's own stem cells). Chemotherapy drugs can damage the cells lining the small blood vessels in the liver as well
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
4-Sep-2002


Page: 1 2 3

Related medicine news :

1. Study shows promise in identifying kidney failure
2. Study shows patch therapy may be as effective as oral medications
3. Study shows soy is well accepted in school lunches
4. Chronic pain treatments more effective when taken together, new study shows
5. UW study shows blacks and Latinos are more satisfied with physicians of the same race
6. Vaccine against childhood pneumonia shows promise
7. UW research shows risk factors for relapse among health care professionals who abuse drugs
8. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
9. New technique shows promise for improved straightening of crooked nose
10. Chemical decoy shows promise for slowing Alzheimers by acting as decoy
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... FORT LAUDERDALE, Fla. (PRWEB) , ... August 05, ... ... management company, today announced the appointments of Kathleen Cruger as Director of Clinical ... team and accelerate the company’s growth. , “ChronWell has achieved incredible ...
(Date:8/5/2020)... ... ... CentrAlert, Inc. today announced the launch of their free ... NOW!, which is available for Apple and Android , seeks to ... application. , “When COVID-19 first hit, there was so much that we didn’t know,” ...
(Date:8/5/2020)... ... August 04, 2020 , ... Total Spectrum, a ... Disorder (ASD) in Wisconsin, is delighted to announce the grand opening of their ... their newest center, Total Spectrum now proudly serves ten different locations across the ...
(Date:8/5/2020)... ... 04, 2020 , ... Today, Power to Decide’s One Key Question ... 2020 Innovation Station Best Practice Award. The One Key Question program is a transformative ... pregnant and have a child. One Key Question is used by thousands of health ...
(Date:8/3/2020)... ... August 03, 2020 , ... ... launch of its newest product, CoverageCoach. The site provides a simple and efficient ... insurance products. The company sees CoverageCoach as an important expansion for the insurance ...
Breaking Medicine News(10 mins):
(Date:8/12/2020)... ... 12, 2020 , ... As the new school year nears, ... the more than 1 million U.S. children who receive school-based treatment for speech ... and modified in-person learning environments. , Virtual Settings , Below are some ...
(Date:8/11/2020)... ... August 11, 2020 , ... ... in-home senior care services, continues its recent expansion reaching nine new franchise ... both South Jersey and Philadelphia regions, One You Love Homecare’s expansion includes ...
(Date:8/7/2020)... ... 07, 2020 , ... Bay State Physical Therapy, Massachusetts' leading ... partnered with Comprehensive Physical Therapy in West Brookfield and Leicester. , ... a strong reputation for providing high-quality clinical care with a patient centered approach. ...
Breaking Medicine Technology:
Cached News: